AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE AND THE LAWS OF DELAWARE RELATING TO THE DISTRIBUTION OF FUNDS FROM THE PRESCRIPTION OPIOID IMPACT FEE AND COURT SETTLEMENTS.
Summary
Delaware has been irreparably harmed by the opioid crisis. In 2018, 400 people died of an overdose in Delaware, and in 2019, 431 people died of an overdose. Settlements from opioid distributors, manufacturers, and pharmacies are expected to provide significant monies over a substantial period of time to Delaware. These funds are intended to address to harm caused by the opioid crisis in our communities. This Act establishes the Prescription Opioid Settlement Fund (Settlement Fund) and Prescription Opioid Distribution Commission (Commission), to ensure that settlement money is used to remediate and abate the opioid crisis and is not diverted to other purposes. The Commission is part of the Behavioral Health Consortium and is established to ensure that decisions on how to spend funds are reached through consensus driven process that takes into account the views and experience of affected communities. The Behavioral Health Consortium will distribute money received by the Settlement Fund and the Prescription Opioid Impact Fund (Impact Fund), enacted by Senate Bill No. 34 of the 150th General Assembly, according to the recommendations of the Commission. The Commission shall seek input from the public and relevant stakeholders and shall convene a Local Government Committee to ensure that recommendations from counties and municipal governments are carefully considered. The terms of settlement agreements, bankruptcy plans, or other agreements for the payment of monies by defendants in opioid-related litigation will likely include terms that establish how the money must be spent. The Commission is required to adhere to those terms. The Commission must produce an annual report regarding the receipt and disbursement of funds. This Act preserves the status quo of the existing parties to litigation while limiting the ability for new local government opioid suits to be brought, because new lawsuits could limit the size of Delaware’s recovery in global settlements that are expected to be reached. This Act repeals the sunset of the Prescription Opioid Impact Fee (Impact Fee) and Impact Fund It also repeals the report requirement for the Impact Fund because the information in that report will be included in the new report that the Commission must produce. This Act requires a greater than majority vote for passage because § 4 of Article VIII of the Delaware Constitution requires the affirmative vote of three-quarters of the members elected to each house of the General Assembly to appropriate funds to a county or municipality. This Act also requires a greater than majority vote for passage because § 1 of Article IX of the Delaware Constitution requires the affirmative vote of two-thirds of the members elected to each house of the General Assembly to amend a charter issued to a municipal corporation.
Bill status
signed
all 5 stages cleared
Introduction
Jun 2021
Committee Review
Jun 2021
Senate Passage
Jun 2021
House Passage
Jun 2021
Signed into Law
Oct 2021
Introduced Jun 3, 2021
Signed Oct 14, 2021
Floor votes · House Jun 29, 2021
How they voted
This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history
Actions timeline
Total actions
10
Key actions
6
Committee
2
Amendments
2
Oct 14, 2021
Signed into law
Signed by Governor
executive
Jun 29, 2021
Lower · Passed
Passed By House. Votes: 41 YES
lower
Jun 23, 2021
Lower · Passed
Reported Out of Committee (Administration) in House with 5 On Its Merits
lower
Jun 17, 2021
Introduced
Re-Assigned to Administration Committee in House
lower
Jun 17, 2021
Introduced
Assigned to Health & Human Development Committee in House
lower
Jun 16, 2021
Upper · Passed
Passed By Senate. Votes: 19 YES 1 NOT VOTING 1 ABSENT
upper
Jun 16, 2021
Upper · Passed
Amendment SA 1 to SB 166 - Passed By Senate. Votes: 19 YES 1 NOT VOTING 1 ABSENT
upper
Jun 16, 2021
Introduced
Amendment SA 1 to SB 166 - Introduced and Placed With Bill
upper
Jun 9, 2021
Upper · Passed
Reported Out of Committee (Health & Social Services) in Senate with 4 Favorable, 1 On Its Merits
upper
Jun 3, 2021
Introduced
Introduced and Assigned to Health & Social Services Committee in Senate
upper
9 primary · 18 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Bryan Townsend
DDemocratic
P
Danny Short
RRepublican
P
Darius Brown
DDemocratic
P
Dave Sokola
DDemocratic
P
DB
David Bentz
DDemocratic
P
JL
John L. Mitchell
DDemocratic
P
Pete Schwartzkopf
DDemocratic
P
Stephanie Hansen
DDemocratic
P
Tizzy Lockman
DDemocratic
Co
Brian Pettyjohn
RRepublican
Co
BC
Bruce C. Ennis
DDemocratic
Co
Bryant Richardson
RRepublican
Co
CB
Colin Bonini
RRepublican
Co
Dave Lawson
RRepublican
Co
Dave Wilson
RRepublican
Co
EB
Ernesto B. Lopez
RRepublican
Co
Gerald Hocker
RRepublican
Co
Jack Walsh
DDemocratic
Co
Laura Sturgeon
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about SB 166
Scope: DE
Hi! I can help you understand SB 166. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline